Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin in Glycogen Storage Disease type 1b
jRCTs071210064Recruiting
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of empagliflozin in glycogen storage disease type 1b. Primary endpoint: Number of neutrophils in the blood. Started Sep 2021; status: recruiting.
02
Drugs
empagliflozin
03
Conditions
glycogen storage disease type 1b
Beyond the preview
Go deeper on jRCTs071210064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071210064.